Clinical Trials Browser

Terminated × Lymphoma, Follicular × idelalisib × Clear all

NCT03890289 2024-11-21

GAUDEALIS

Phase 2 Terminated

5 enrolled 13 charts

Lymphoma, Follicular

NCT04699461 2023-10-23

LOTIS-6

Phase 2 Terminated

6 enrolled 9 charts

Lymphoma, Lymphoma, Follicular

NCT02536300 2023-08-14

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Phase 3 Terminated

96 enrolled 22 charts

Lymphoma, Follicular

NCT02258529 2019-05-14

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Phase 2 Terminated

10 enrolled 10 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01732926 2018-11-16

Bridalveil

Phase 3 Terminated

475 enrolled 9 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone